All stock lists
RxSight, Inc. (NASDAQ:RXST)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
5.00-0.01 (-0.30%)
Insider Score
––Not scored
RXST Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RXST analyst forecast
RXST analyst consensus
Hold4 ratings
Buy 0 Hold 3 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
RXST 12-month price target
No published price targets in the last 12 months.
Best analysts covering RXST
- JP Morgan50%success rate · 4 calls
- B of A Securities50%success rate · 2 calls
- Needham44%success rate · 25 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
RXST analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Jefferies | Hold | — | — | Reiterated | 2026-09-22 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2026-09-22 |
| — | Stifel | Hold | — | — | Reiterated | 2026-08-10 |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-07-07 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2026-07-07 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-07 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-05-07 |
| — | Stifel | Hold | — | — | Reiterated | 2026-03-09 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-02-26 |
| — | UBS | Neutral | — | — | Reiterated | 2026-02-26 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-26 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-01-20 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-12-02 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-06 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-11-06 |
| — | Needham | Buy | — | — | Reiterated | 2025-11-06 |
| — | Stifel | Hold | — | — | Reiterated | 2025-08-08 |
| — | UBS | Neutral | — | — | Reiterated | 2025-08-08 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-08 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2025-07-15 |
| — | Jefferies | Hold | — | — | Downgraded | 2025-07-10 |
| — | BTIG | Neutral | — | — | Downgraded | 2025-07-09 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2025-07-09 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-07-09 |
| — | Stifel | Hold | — | — | Reiterated | 2025-07-09 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2025-07-09 |
| — | Needham | Buy | — | — | Reiterated | 2025-07-09 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2025-05-19 |
| — | UBS | Neutral | — | — | Downgraded | 2025-04-09 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-08 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-04-07 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2025-04-04 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-04-03 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-03 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-03-21 |
| — | Stifel | Hold | — | — | Reiterated | 2025-03-19 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-26 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-02-26 |
| — | Stifel | Hold | — | — | Reiterated | 2025-02-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-02-26 |
| — | Stifel | Hold | — | — | Reiterated | 2025-01-13 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-01-13 |
| — | Needham | Buy | — | — | Reiterated | 2025-01-13 |
| — | Stifel | Hold | — | — | Downgraded | 2024-12-20 |
| — | Needham | Buy | — | — | Reiterated | 2024-12-17 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2024-12-11 |
| — | Needham | Buy | — | — | Reiterated | 2024-09-13 |
| — | Needham | Buy | — | — | Reiterated | 2024-08-20 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-08-06 |
| — | Stifel | Buy | — | — | Reiterated | 2024-08-06 |
| — | Needham | Buy | — | — | Reiterated | 2024-08-06 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-08-06 |
| — | BTIG | Buy | — | — | Reiterated | 2024-07-15 |
| — | Stifel | Buy | — | — | Reiterated | 2024-07-10 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-05-07 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-05-07 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-07 |
| — | BTIG | Buy | — | — | Reiterated | 2024-05-07 |
| — | Stifel | Buy | — | — | Reiterated | 2024-05-06 |
RXST earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | -0.33 | -0.22 | $30.2M | $32.6M |
| 2026-05-06 | -0.30 | -0.38 | $29.8M | $30.9M |
| 2026-08-05 | -0.33 | -0.29 | $32.5M | $33.7M |
| 2026-11-03 | -0.29 | 0.00 | $27.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.